Home

Order to parcel locker
easy pay

Reduced price

Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment

See next edition:

Kaplan and Sadock's Pocket Handbook of Psychiatric Drug Treatment

Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment

Authors:

Brand: Lippincott Williams & Wilkins

ISBN: 9781609139681

296.10 zł

266.49 zł Save 29.61 zł Tax included

Lowest price within 30 days before promotion: 266.49 zł

Quantity

Product unavailable

Out of print

Notify me about new stock Enter your email address to get notifications about new stock of this product

Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

Kaplan & Sadocks Pocket Handbook of Psychiatric Drug Treatment covers the entire spectrum of clinical drug therapy for adults, elderly adults, pregnant and nursing women, and children. Drugs are listed alphabetically, for quick navigation, and each drug entry includes name, molecular structure, dosing, pharmacological actions, indications and clinical applications, side effects and adverse/allergic reactions, and drug interactions. In the front are tables listing the chapters where each drug is discussed and the common disorders for which each is used. Color drug plates in the front help with rapid recognition of all major drugs.

Product Details

Brand Lippincott Williams & Wilkins

Reference 48779

EAN13 9781609139681

ISBN 9781609139681

Data sheet

Publication date: 2011
Issue number: 5
Cover: paperback
Pages count: 320
Dimensions (mm): 127 x 203

Contents
Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
1. General Principles of Psychopharmacology . . . . . . . . . . . . . . . . . . . . . . . . . 1
2. α2-Adrenergic Receptor Agonists, α1-Adrenergic Receptor Antagonists:
Clonidine, Guanfacine, Minipress and Yohimbine. . . . . . . . . . . . . . . . . . . . 25
3. β-Adrenergic Receptor Antagonists . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
4. Anticholinergics and Amantadine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
5. Anticonvulsants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
6. Antihistamines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
7. Barbiturates and Similarly Acting Drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
8. Benzodiazepines and Drugs Acting on Benzodiazepine Receptors . . . . . 68
9. Bupropion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
10. Buspirone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
11. Calcium Channel Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
12. Carbamazepine and Oxcarbazepine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
13. Cholinesterase Inhibitors and Memantine . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
14. Disulfiram and Acamprosate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
15. Dopamine Receptor Agonists and Precursors . . . . . . . . . . . . . . . . . . . . . . . . 113
16. Dopamine Receptor Antagonists (First Generation Antipsychotics) . . . . 118
17. Lamotrigine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
18. Lithium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
19. Melatonin Agonists: Ramelton and Melatonin . . . . . . . . . . . . . . . . . . . . . . . 157
20. Mirtazapine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
21. Monoamine Oxidase Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
22. Nefazodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
23. Opioid Receptor Agonists: Methadone and Buprenorphine . . . . . . . . . . . 174
24. Opioid Receptor Antagonists: Naltrexone, Nalmefene, and Naloxone . . 181
25. Phosphodiesterase-5 Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188
26. Selective Serotonin–Norepinephrine Reuptake Inhibitors . . . . . . . . . . . . . 193
27. Selective Serotonin Reuptake Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200
28. Serotonin–Dopamine Antagonists and Similarly Acting Drugs
(Second Generation or Atypical Antipsychotics) . . . . . . . . . . . . . . . . . . . . . 217
29. Sympathomimetics and Related Drugs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 238
30. Thyroid Hormones . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 248
31. Trazodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 251
32. Tricyclics and Tetracyclics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 255
33. Valproate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 266
34. Nutritional Supplements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 274
35. Intoxication and Overdose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 288
Index. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 299
About the Authors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 315

See next edition:

Kaplan and Sadock's Pocket Handbook of Psychiatric Drug Treatment

Comments (0)

Frequently purchased together

No products available

Cookie name	Provider	Purpose	Expiry
cookiesplus	https://medbook.com.pl	Stores your cookie preferences.	1 year
PHP_SESSID	https://medbook.com.pl	This cookie is native to PHP and enables websites to store serialised state data. It is used to establish a user session and to pass state data via a temporary cookie, which is commonly referred to as a session cookie.	Session
PrestaShop-#	https://medbook.com.pl	This cookie helps keep user sessions open while they are visiting a website, and help them make orders and many more operations such as: cookie add date, selected language, used currency, last product category visited, last seen products, client identification, name, first name, encrypted password, email linked to the account, shopping cart identification.	480 hours

Cookie name	Provider	Purpose	Expiry
fr	Facebook	Used by Facebook to deliver a series of advertisement products such as real time bidding from third party advertisers.	3 months
tr	Facebook	Used by Facebook to deliver a series of advertisement products such as real time bidding from third party advertisers.	Session
_fbp	Facebook	Used by Facebook to deliver a series of advertisement products such as real time bidding from third party advertisers.	3 months

See next edition:

Kaplan and Sadock's Pocket Handbook of Psychiatric Drug Treatment

Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment

See next edition:

Kaplan and Sadock's Pocket Handbook of Psychiatric Drug Treatment

Frequently purchased together